Regulators should reach a decision about whether to approve Canada’s first COVID-19 vaccine for infants and preschoolers in coming weeks, federal officials said Friday as the United States prepared to roll out tot-sized shots.
Deputy chief public health officer Dr. Howard Njoo said that Health Canada continues to review Moderna’s application for a vaccine to protect children between six months and five years old.
“We anticipate a decision in the coming, I would say, weeks or so. I can’t give you a precise date,” Njoo told a virtual press conference. “Obviously, they need to do their due diligence.”